Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:631-637
Published online before print August 25, 2008, doi: 10.1161/HYPERTENSIONAHA.108.110635
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
52/4/631    most recent
HYPERTENSIONAHA.108.110635v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flynn, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flynn, J. T.
Related Collections
Right arrow Other hypertension
Right arrow Clinical Studies
Right arrow Other etiology
Right arrow Other Treatment
Right arrow Epidemiology
Right arrowRelated Article

(Hypertension. 2008;52:631.)
© 2008 American Heart Association, Inc.


Original Articles

Blood Pressure in Children With Chronic Kidney Disease

A Report From the Chronic Kidney Disease in Children Study

Joseph T. Flynn; Mark Mitsnefes; Christopher Pierce; Steven R. Cole; Rulan S. Parekh; Susan L. Furth; Bradley A. Warady for the Chronic Kidney Disease in Children Study Group

From the Children’s Hospital and Regional Medical Center (J.T.F.), Seattle, Wash; Children’s Hospital Medical Center (M.M.), Cincinnati, Ohio; Johns Hopkins University School of Public Health (C.P., S.R.C., R.S.P., S.L.F.), Baltimore, Md; and Children’s Mercy Hospital (B.A.W.), Kansas City, MO.

Correspondence to Joseph T. Flynn, MD, MS, Division of Nephrology, A-7931, Children’s Hospital & Regional Medical Center, 4800 Sand Point Way NE, Seattle, WA 98105. E-mail joseph.flynn{at}seattlechildrens.org

To characterize the distribution of blood pressure (BP), prevalence, and risk factors for hypertension in pediatric chronic kidney disease, we conducted a cross-sectional analysis of baseline BPs in 432 children (mean age 11 years; 60% male; mean glomerular filtration rate 44 mL/min per 1.73 m2) enrolled in the Chronic Kidney Disease in Children cohort study. BPs were obtained using an aneroid sphygmomanometer. Glomerular filtration rate was measured by iohexol disappearance. Elevated BP was defined as BP ≥90th percentile for age, gender, and height. Hypertension was defined as BP ≥95th percentile or as self-reported hypertension plus current treatment with antihypertensive medications. For systolic BP, 14% were hypertensive and 11% were prehypertensive (BP 90th to 95th percentile); 68% of subjects with elevated systolic BP were taking antihypertensive medications. For diastolic BP, 14% were hypertensive and 9% were prehypertensive; 53% of subjects with elevated diastolic BP were taking antihypertensive medications. Fifty-four percent of subjects had either systolic or diastolic BP ≥95th percentile or a history of hypertension plus current antihypertensive use. Characteristics associated with elevated BP included black race, shorter duration of chronic kidney disease, absence of antihypertensive medication use, and elevated serum potassium. Among subjects receiving antihypertensive treatment, uncontrolled BP was associated with male sex, shorter chronic kidney disease duration, and absence of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use. Thirty-seven percent of children with chronic kidney disease had either elevated systolic or diastolic BP, and 39% of these were not receiving antihypertensives, indicating that hypertension in pediatric chronic kidney disease may be frequently under- or even untreated. Treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers may improve BP control in these patients.


Key Words: ACE inhibitors • adolescents • blood pressure • children • hypertension • kidney disease


Related Article:

Hypertension in Children With Chronic Kidney Disease: A Call to Action
Carmen A. Peralta and Michael G. Shlipak
Hypertension 2008 52: 610-612. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
J. T. Flynn
Hypertension in the young: epidemiology, sequelae and therapy
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 370 - 375.
[Full Text] [PDF]


Home page
HypertensionHome page
C. A. Peralta and M. G. Shlipak
Hypertension in Children With Chronic Kidney Disease: A Call to Action
Hypertension, October 1, 2008; 52(4): 610 - 612.
[Full Text] [PDF]